Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase Expands Intellectual Property Portfolio

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jun 28, 2022 8:32am

234 Views

Post# 34786825

RE:RE:RE:New Press Release - Theralase Expands Intellectual Property Portfolio

Only one big pharma will be able to salivate. And it has to be faster than its competitors, given the size of the market shares, if we clearly have impressive durable response.

So it will be interesting to hear about the 270-day data for the 11 patients that had received their 180-day dose (maintenance dose) but for which their data 270-day was still pending.

<< Previous

Bullboard Posts

Next >>

Cannabix advances marijuana breathalyzer tech